Evidence map›Paper›PMID 42666655›Full record

ArticleCureus2026

Correction of Alkalemia in a Hemodialysis Patient: A Case Report.

Ying H Luu, Hamid R Hajmomenian, Reza Khorsan

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ying H LuuMedicine/Nephrology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, USA.
Hamid R HajmomenianMedicine/Nephrology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, USA.
Reza KhorsanMedicine/Nephrology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advanced chronic kidney disease, including end-stage renal disease (ESRD), typically leads to chronic progressive metabolic acidosis and acidemia due to reduced renal excretion of daily acid loads, particularly impaired ammonium excretion. Metabolic acidosis and acidemia typically develop as kidney function progressively declines. It is characterized by a low serum bicarbonate level and a high or normal anion gap. Alkalemia is relatively rare in ESRD but is a life-threatening condition. We present a case of a woman in her 70s with ESRD and severe alkalemia due to respiratory alkalosis, successfully treated with low-bicarbonate dialysate.

Indexed as

alkalemiaend-stage renal disease (esrd)hemodialysislow-bicarbonate dialysaterespiratory alkalosis

Identifiers

PMID42666655
PMCPMC13522693

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.